Tag: radiation
-
Statins During Radiotherapy for High-Risk Prostate Cancer Improve Outcomes – Renal and Urology News
Statins During Radiotherapy for High-Risk Prostate Cancer Improve Outcomes via Statins During Radiotherapy for High-Risk Prostate Cancer Improve Outcomes – Renal and Urology News. Statins are medicines that are taken to lower cholesterol. Many studies have shown they are beneficial in preventing heart disease and many diseases. Some experts believe that these medicines help prevent…
-
The Prognostic Impact of Seminal Vesicle Involvement Found at Prostatectomy and the Effects of Adjuvant Radiation
Source: Urotoday Patients with seminal vesicle positive disease who received adjuvant radiation compared to observation realized an improvement in 10-year biochemical failure-free survival from 12% to 36% (p = 0.001), in 10-year overall survival from 51% to 71% (p = 0.08) and in metastasis-free survival from 47% to 66% (p = 0.09), respectively. Although seminal…
-
MedWire News – Prostate Cancer – Endocrine and radiotherapy ‘standard care’ for locally advanced prostate cancer
Source Medwire News Adding local radiotherapy to endocrine treatment halves the 10-year prostate cancer-specific mortality in patients with locally advanced or high-risk local prostate cancer compared with endocrine treatment alone, researchers report. “In the light of these data, endocrine treatment plus radiotherapy should be the new standard,” Anders Widmark (Umeå University, Sweden) and team write…
-
Medical News: ASTRO: Proton Radiation Fails to Impress in Prostate Cancer Study – in Meeting Coverage, ASTRO
Source: Med page today Proton radiation for early prostate cancer had an acceptable tolerability profile but produced little evidence of a “gee whiz” impact to support its cost, according to preliminary results from a phase I/II clinical trial. Two-thirds of patients had acute genitourinary or gastrointestinal toxicity, and a third had late GU/GI toxicity, Anthony…
-
Prostate Cancer-Specific Survival Following Salvage Radiotherapy vs Observation in Men With Biochemical Recurrence After Radical Prostatectomy: Abstract
Source: JAMA Prostate Cancer-Specific Survival Following Salvage Radiotherapy vs Observation in Men With Biochemical Recurrence After Radical Prostatectomy Bruce J. Trock, PhD; Misop Han, MD; Stephen J. Freedland, MD; Elizabeth B. Humphreys, MS; Theodore L. DeWeese, MD; Alan W. Partin, MD, PhD; Patrick C. Walsh, MD JAMA. 2008;299(23):2760-2769. Context Biochemical disease recurrence after radical prostatectomy…
-
IMRT external beam radiation review
UroToday – Current Status of Intensity-Modulated Radiation Therapy (IMRT) In the International Journal of Clinical Oncology, Dr. Hatano and colleagues from Chiba, Japan provide an excellent overview of intensity-modulated radiation therapy (IMRT). Problems with conventional, four field radiotherapy have been ineffective dose distribution and overdoses to organs at risk (OARs), such as the bladder and…
-
Swiss study shows survival advantage for surgery over radiation therapy for prostate cancer
Prostate Cancer: Surgery Best Option? Men who choose surgery for early prostate cancer are more likely to be alive 10 years later than men who opt for other treatments, a Swiss study shows. “If you look not only at this study but at the studies we brought out in the last three or four years,…
-
Salvage radiation after prostate cancer surgery
UroToday – Predicting the Outcome of Salvage Radiation Therapy for Recurrent Prostate Cancer after Radical Prostatectomy This retrospective study with a large cohort of patients treated with salvage radiotherapy after prostatectomy suggests that up to 50% of patients may remain free of disease 6 years after treatment if it is instituted before their serum PSA…
-
Hormonal therapy with radiation for prostate cancer
UroToday – Phase II Study of Neoadjuvant Androgen Deprivation Followed by External-Beam Radiotherapy With 9 Months of Androgen Deprivation for Intermediate- to High-Risk Localized Prostate Cancer Testosterone returned to normal in 69% of patients with a median time to recovery of 9 months. Testosterone returned to it baseline level after ADT in 37% with a…